Cardiotoxicity with human epidermal growth factor receptor-2 inhibitors in breast cancer: Disproportionality analysis of the FDA adverse event reporting system
- Resource Type
- Article
- Source
- In
International Journal of Cardiology 15 March 2023 375:87-93 - Subject
- Language
- ISSN
- 0167-5273